StockNews.com Begins Coverage on ObsEva (NASDAQ:OBSV)

StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock.

ObsEva Price Performance

ObsEva has a 52 week low of $0.08 and a 52 week high of $2.14. The stock has a market capitalization of $7.94 million, a price-to-earnings ratio of -0.11 and a beta of 0.68.

About ObsEva

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.